Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Feb;54(2):256-9.
doi: 10.1002/pbc.22282.

Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial

Steven G Pavlakis  1 , Renée C Rees, Xiangke Huang, R Clark Brown, James F Casella, Rathi V Iyer, Ram Kalpatthi, Judy Luden, Scott T Miller, Zora R Rogers, Courtney D Thornburg, Winfred C Wang, Robert J Adams; BABY HUG Investigators
Affiliations
Multicenter Study

Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial

Steven G Pavlakis et al. Pediatr Blood Cancer. 2010 Feb.

Abstract

Background: Transcranial Doppler ultrasonography (TCD) is used to predict stroke risk in children with sickle cell anemia (SCA), but has not been adequately studied in children under age 2 years.

Procedure: TCD was performed on infants with SCA enrolled in the BABY HUG trial. Subjects were 7-17 months of age (mean 12.6 months). TCD examinations were successfully performed in 94% of subjects (n = 192).

Results: No patient had an abnormal TCD as defined in the older child (time averaged maximum mean TAMM velocity > or =200 cm/sec) and only four subjects (2%) had velocities in the conditional range (170-199 cm/sec). TCD velocities were inversely related to hemoglobin (Hb) concentration and directly related to increasing age.

Conclusion: Determination of whether the TCD values in this very young cohort of infants with SCA can be used to predict stroke risk later in childhood will require analysis of exit TCD's and long-term follow-up, which is ongoing (ClinicalTrials.gov number, NCT00006400).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Highest Time averaged mean maximum velocity (TAMM) vs. Age, Hemoglobin (Hb), and Absolute Reticulocyte Count (ARC) Expressed as the square Root of the Value.
See this image and copyright information in PMC

Comment in

References

    1. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326:605–610. - PubMed
    1. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med. 1998;339:5–15. - PubMed
    1. Prengler M, Pavlakis SG, Prohovnik I, Adams RJ. Sickle cell disease: the neurological complications. Ann Neurol. 2002;51:543–552. - PubMed
    1. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cooperative study of sickle cell disease: cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288–294. - PubMed
    1. Wang WC, Pavlakis SG, Helton KJ, et al. MRI abnormalities in the Brain in One Year old Children with Sickle Cell Anemia. Pediatr Blood Cancer. 2008;51:643–646. - PubMed

Publication types

Associated data